LRTX Share Price Performance
US$0
0.00 (0.00%)
Price US$0
Share Pricen/a
Lirum Therapeutics, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
LRTX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Lirum Therapeutics, Inc. Key Details
About LRTX
- Founded
- 2021
- Employees
- 3
- CEO
- WebsiteView website
Lirum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the treatment of debilitating diseases. Its lead product candidate is LX-101, an insulin-like growth factor-1 receptor directed agent to treat patients with various cancers and autoimmune diseases, including thyroid eye disease. The company was incorporated in 2021 and is based in New York, New York.
Recent LRTX News & Updates
No updates
